Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
1
2014
FDA (Food and Drug Administration) Issues Long-Awaited Draft Guidance Documents Concerning Internet/Social Media Covington & Burling LLP
Jul
1
2014
Energy & Environmental Law Update - June 30, 2014 Mintz
Jun
30
2014
FDA Gives an Inch, But Only an Inch, on Use of Social Media to Promote Drugs and Devices Barnes & Thornburg LLP
Jun
30
2014
FDA Issues Guidance on Use of Nanotechnology in Foods Barnes & Thornburg LLP
Jun
30
2014
Trademark Rights around the World: It May Be BUDWEISER® in the US, But Not Everywhere Mintz
Jun
30
2014
Supreme Court: Food, Drug, and Cosmetic Act (FDCA) Compliance Does Not Bar Lanham Act Claims - POM Wonderful LLC v. Coca-Cola Co. McDermott Will & Emery
Jun
28
2014
Comment Period Closing Soon on New Food and Drug Administration (FDA) Food Transport Rule Beveridge & Diamond PC
Jun
27
2014
FDA Draft Guidance - Best Practices for Developing Drug Trademarks - Food and Drug Administration Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
27
2014
Federal Judge Puts Narcolepsy Drug Horizontal Conspiracy Claims to Bed McDermott Will & Emery
Jun
26
2014
VitaminsOnline.com Files False Advertising Action Over Competitor's Online Dietary Supplement Offerings and Claims Womble Bond Dickinson (US) LLP
Jun
26
2014
Making Use of Social Media: FDA Releases Two Draft Guidelines on the Use of Social Media Platforms by Drug and Device Manufacturers Mintz
Jun
25
2014
Is an Abbreviated Pathway for Biosimilars Coming Soon to China? Michael Best & Friedrich LLP
Jun
24
2014
Food and Drug Administration (FDA) Relaxes Regulation of Certain Software Devices Covington & Burling LLP
Jun
24
2014
Food and Drug Administration (FDA) to Cease Active Regulation of Medical Device Data Systems (MDDS) and Other Health IT Devices Morgan, Lewis & Bockius LLP
Jun
23
2014
340B Registration Changes: Re-enrollment of Currently Participating Facilities and Eligibility Based on Amended Cost Reports McDermott Will & Emery
Jun
23
2014
Food and Drug Administration (FDA) Issues Draft Guidance Docs On How To Provide Accurate Risk/Benefit Info in 140 Characters Or Less And Clean Up 3rd Party UGC [129/140] Proskauer Rose LLP
Jun
20
2014
FDA Issues Draft Guidance Easing Compliance for Medical Device Data and Image Systems - Food and Drug Administration Mintz
Jun
20
2014
Milk Processors Soured After Federal District Court Rules They Must Face Monopsonization Claims at Trial Mintz
Jun
19
2014
Supreme Court Rules Compliance with Food and Drug Administration (FDA) Labeling Guidelines Does Not Bar Lanham Act False Advertising Suits – POM Wonderful v. Coca-Cola Co. Sheppard, Mullin, Richter & Hampton LLP
Jun
19
2014
Alice v. CLS Bank: Supreme Court Continues to Grope in Dark for Contours of Abstract Idea Exception Schwegman, Lundberg & Woessner, P.A.
Jun
19
2014
Health Resources and Services Administration (HRSA) “Interprets” Its Enjoined 340 Orphan Drug Rule into Effect Mintz
Jun
18
2014
Grocery Manufacturers File Suit Against Vermont Over Genetically Modified Organisms (GMO) Law Mintz
Jun
17
2014
Supreme Court Rules Competitors Can Bring Suit Against FDA-Regulated Labels McDermott Will & Emery
Jun
17
2014
Natural Products Eligibility Guidance – Post-Forum Comments
Jun
16
2014
FDA Issues Draft Guidance on Distributing Favorable New Risk Information for Drugs Barnes & Thornburg LLP
Jun
13
2014
U.S. Supreme Court: Pom’s Mislabeling Suit Against Coke Not Precluded by FDA Regulations - Food and Drug Administration Mintz
Jun
13
2014
Supreme Court Holds Competitors May Bring False, Misleading Product Descriptions Claims on Food, Beverage Labels Barnes & Thornburg LLP
Jun
13
2014
Cloning: It’s not what you think – Changes to ANVISA’s (Brazil Health Service Agency) “Clone” Procedure Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins